These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20105183)

  • 21. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.
    Gao ZG; Ye K; Göblyös A; Ijzerman AP; Jacobson KA
    BMC Pharmacol; 2008 Dec; 8():20. PubMed ID: 19077268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.
    Massink A; Holzheimer M; Hölscher A; Louvel J; Guo D; Spijksma G; Hankemeier T; IJzerman AP
    Purinergic Signal; 2015 Dec; 11(4):581-94. PubMed ID: 26482925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors.
    Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation.
    Cordeaux Y; Ijzerman AP; Hill SJ
    Br J Pharmacol; 2004 Nov; 143(6):705-14. PubMed ID: 15302686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers.
    Vernall AJ; Stoddart LA; Briddon SJ; Ng HW; Laughton CA; Doughty SW; Hill SJ; Kellam B
    Org Biomol Chem; 2013 Sep; 11(34):5673-82. PubMed ID: 23881285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tritium-labeled agonists as tools for studying adenosine A
    Hinz S; Alnouri WM; Pleiss U; Müller CE
    Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.
    Heitman LH; Mulder-Krieger T; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Dalpiaz A; IJzerman AP
    Br J Pharmacol; 2006 Mar; 147(5):533-41. PubMed ID: 16444290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of fluorescence correlation spectroscopy to the measurement of agonist binding to a G-protein coupled receptor at the single cell level.
    Briddon SJ; Middleton RJ; Yates AS; George MW; Kellam B; Hill SJ
    Faraday Discuss; 2004; 126():197-207; discussion 245-54. PubMed ID: 14992407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.
    Peakman MC; Hill SJ
    Br J Pharmacol; 1994 Jan; 111(1):191-8. PubMed ID: 8012696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.
    Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN
    Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.
    Nguyen AT; Baltos JA; Thomas T; Nguyen TD; Muñoz LL; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
    Mol Pharmacol; 2016 Dec; 90(6):703-714. PubMed ID: 27683014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
    Bevan N; Butchers PR; Cousins R; Coates J; Edgar EV; Morrison V; Sheehan MJ; Reeves J; Wilson DJ
    Eur J Pharmacol; 2007 Jun; 564(1-3):219-25. PubMed ID: 17382926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells.
    Alexander SP; Cooper J; Shine J; Hill SJ
    Br J Pharmacol; 1996 Nov; 119(6):1286-90. PubMed ID: 8937736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosteric modulators affect the internalization of human adenosine A1 receptors.
    Klaasse EC; van den Hout G; Roerink SF; de Grip WJ; Ijzerman AP; Beukers MW
    Eur J Pharmacol; 2005 Oct; 522(1-3):1-8. PubMed ID: 16214128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing the binding site of the A1 adenosine receptor reengineered for orthogonal recognition by tailored nucleosides.
    Palaniappan KK; Gao ZG; Ivanov AA; Greaves R; Adachi H; Besada P; Kim HO; Kim AY; Choe SA; Jeong LS; Jacobson KA
    Biochemistry; 2007 Jun; 46(25):7437-48. PubMed ID: 17542617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacological studies on the A2 adenosine receptor agonist 5'-n-ethyl-carboxamidoadenosine and its F19 isotope labelled derivative.
    Rubovszky B; Szentmiklósi AJ; Márián T; Cseppento A; Gesztelyi R; Székely A; Fórizs F; Gáspár R; Trón L; Krasznai Z
    J Pharmacol Sci; 2003 Nov; 93(3):356-63. PubMed ID: 14646254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescent-Labeled Selective Adenosine A
    Köse M; Gollos S; Karcz T; Fiene A; Heisig F; Behrenswerth A; Kieć-Kononowicz K; Namasivayam V; Müller CE
    J Med Chem; 2018 May; 61(10):4301-4316. PubMed ID: 29681156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of A1 adenosine receptor ligand [3H]8-cyclopentyl-1,3-dipropylxanthine in coronary smooth muscle.
    Hussain T; Mustafa SJ
    Circ Res; 1995 Jul; 77(1):194-8. PubMed ID: 7788877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
    Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.